NO20055835L - Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents
Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende demInfo
- Publication number
- NO20055835L NO20055835L NO20055835A NO20055835A NO20055835L NO 20055835 L NO20055835 L NO 20055835L NO 20055835 A NO20055835 A NO 20055835A NO 20055835 A NO20055835 A NO 20055835A NO 20055835 L NO20055835 L NO 20055835L
- Authority
- NO
- Norway
- Prior art keywords
- processes
- preparation
- pharmaceutical compositions
- compositions containing
- cyclic amine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0310724.0A GB0310724D0 (en) | 2003-05-09 | 2003-05-09 | Chemical compounds |
| PCT/EP2004/005005 WO2004099143A1 (en) | 2003-05-09 | 2004-05-07 | Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055835D0 NO20055835D0 (no) | 2005-12-08 |
| NO20055835L true NO20055835L (no) | 2006-02-07 |
Family
ID=9957781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055835A NO20055835L (no) | 2003-05-09 | 2005-12-08 | Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20070073061A1 (no) |
| EP (1) | EP1622871A1 (no) |
| JP (1) | JP4684221B2 (no) |
| KR (1) | KR20060009313A (no) |
| CN (1) | CN100534983C (no) |
| AR (1) | AR044269A1 (no) |
| AU (1) | AU2004235967B2 (no) |
| BR (1) | BRPI0410154A (no) |
| CA (1) | CA2524894A1 (no) |
| EG (1) | EG24668A (no) |
| GB (1) | GB0310724D0 (no) |
| IS (1) | IS8164A (no) |
| MA (1) | MA27795A1 (no) |
| MX (1) | MXPA05012096A (no) |
| MY (1) | MY140027A (no) |
| NO (1) | NO20055835L (no) |
| NZ (1) | NZ543068A (no) |
| RU (1) | RU2392270C2 (no) |
| TW (1) | TWI332499B (no) |
| WO (1) | WO2004099143A1 (no) |
| ZA (1) | ZA200508339B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0412865D0 (en) | 2004-06-09 | 2004-07-14 | Glaxo Group Ltd | Chemical compounds |
| US7844037B2 (en) | 2005-08-08 | 2010-11-30 | Palm, Inc. | Method and device for enabling message responses to incoming phone calls |
| EP2094692B1 (en) * | 2006-11-01 | 2012-11-28 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| US20110212997A1 (en) * | 2008-09-01 | 2011-09-01 | Neurosearch A/S | Piperidine-4-acetamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| US9782397B2 (en) | 2011-07-04 | 2017-10-10 | Irbm Science Park S.P.A. | Treatment of corneal neovascularization |
| CN106187999A (zh) * | 2015-05-04 | 2016-12-07 | 复旦大学 | 取代哌啶类化合物及其制备方法和用途 |
| KR20240019754A (ko) * | 2021-03-23 | 2024-02-14 | 바이오에이지 랩스, 인코포레이티드 | Nlrp3 인플라마좀의 억제제 |
| WO2023147468A1 (en) | 2022-01-28 | 2023-08-03 | BioAge Labs, Inc. | N-oxide inhibitors of nlrp3 inflammasome |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US309720A (en) * | 1884-12-23 | William p | ||
| NL262366A (no) * | 1960-03-14 | |||
| GB1356118A (en) * | 1970-12-16 | 1974-06-12 | Searle & Co | 1-3-cyano-3,3-diphenylpropyl-4-phenylpiperidine-4-carboxylic acid derivatives |
| US5635510A (en) * | 1993-05-06 | 1997-06-03 | Merrell Pharmaceuticals Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines |
| DE19603767A1 (de) * | 1996-02-02 | 1997-08-07 | Hoechst Ag | Pyrrolidinpropionsäurederivate mit bradykinin-antagonistischer Wirkung |
| US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| WO1999025685A1 (en) * | 1997-11-18 | 1999-05-27 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| US6423519B1 (en) * | 1998-07-15 | 2002-07-23 | Gpc Biotech Inc. | Compositions and methods for inhibiting fungal growth |
| ES2340147T3 (es) * | 2001-04-12 | 2010-05-31 | Pharmacopeia, Llc | Piperidinas de arilo y biarilo usadas como antagonistas de mch. |
| MXPA04004956A (es) * | 2001-11-26 | 2004-08-11 | Schering Corp | Antagonistas de la hormona concentradora de melanina basados en la piperidina para tratamiento de la obesidad y de trastornos del sistema nervioso central. |
| TW200403058A (en) * | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
| JP2005535650A (ja) * | 2002-07-03 | 2005-11-24 | グラクソ グループ リミテッド | タキキニンアンタゴニストおよびセロトニン再取り込み阻害剤としての置換４−フェニル−ピペリジン−アミド |
-
2003
- 2003-05-09 GB GBGB0310724.0A patent/GB0310724D0/en not_active Ceased
-
2004
- 2004-05-07 KR KR1020057021196A patent/KR20060009313A/ko active IP Right Grant
- 2004-05-07 NZ NZ543068A patent/NZ543068A/xx unknown
- 2004-05-07 MX MXPA05012096A patent/MXPA05012096A/es active IP Right Grant
- 2004-05-07 EP EP04731635A patent/EP1622871A1/en not_active Withdrawn
- 2004-05-07 CN CNB2004800194957A patent/CN100534983C/zh not_active Expired - Fee Related
- 2004-05-07 JP JP2006505412A patent/JP4684221B2/ja not_active Expired - Fee Related
- 2004-05-07 MY MYPI20041688A patent/MY140027A/en unknown
- 2004-05-07 TW TW093112840A patent/TWI332499B/zh not_active IP Right Cessation
- 2004-05-07 CA CA002524894A patent/CA2524894A1/en not_active Abandoned
- 2004-05-07 WO PCT/EP2004/005005 patent/WO2004099143A1/en active Application Filing
- 2004-05-07 AR ARP040101565A patent/AR044269A1/es not_active Application Discontinuation
- 2004-05-07 RU RU2005138315/04A patent/RU2392270C2/ru not_active IP Right Cessation
- 2004-05-07 BR BRPI0410154-5A patent/BRPI0410154A/pt not_active IP Right Cessation
- 2004-05-07 AU AU2004235967A patent/AU2004235967B2/en not_active Ceased
- 2004-05-07 US US10/554,822 patent/US20070073061A1/en not_active Abandoned
-
2005
- 2005-10-14 ZA ZA200508339A patent/ZA200508339B/en unknown
- 2005-10-29 EG EGNA2005000691 patent/EG24668A/xx active
- 2005-11-08 MA MA28584A patent/MA27795A1/fr unknown
- 2005-12-01 IS IS8164A patent/IS8164A/is unknown
- 2005-12-08 NO NO20055835A patent/NO20055835L/no unknown
-
2007
- 2007-10-10 US US11/869,945 patent/US20090192194A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05012096A (es) | 2006-02-08 |
| GB0310724D0 (en) | 2003-06-11 |
| TW200510309A (en) | 2005-03-16 |
| AR044269A1 (es) | 2005-09-07 |
| MY140027A (en) | 2009-11-30 |
| AU2004235967B2 (en) | 2008-10-23 |
| EP1622871A1 (en) | 2006-02-08 |
| IS8164A (is) | 2005-12-01 |
| CN1819995A (zh) | 2006-08-16 |
| EG24668A (en) | 2010-04-11 |
| WO2004099143A1 (en) | 2004-11-18 |
| NZ543068A (en) | 2009-07-31 |
| ZA200508339B (en) | 2006-10-25 |
| RU2392270C2 (ru) | 2010-06-20 |
| RU2005138315A (ru) | 2007-06-20 |
| US20090192194A1 (en) | 2009-07-30 |
| MA27795A1 (fr) | 2006-03-01 |
| NO20055835D0 (no) | 2005-12-08 |
| CA2524894A1 (en) | 2004-11-18 |
| AU2004235967A1 (en) | 2004-11-18 |
| TWI332499B (en) | 2010-11-01 |
| CN100534983C (zh) | 2009-09-02 |
| JP4684221B2 (ja) | 2011-05-18 |
| JP2006525975A (ja) | 2006-11-16 |
| KR20060009313A (ko) | 2006-01-31 |
| US20070073061A1 (en) | 2007-03-29 |
| BRPI0410154A (pt) | 2006-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054329D0 (no) | Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike | |
| NO20052683D0 (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20054876D0 (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser | |
| NO20054006D0 (no) | Cykliske ureaderivater, fremstillingsfremgangsmate derav og farmasoytisk anvendelse av samme som kinaseinhibitorer | |
| DK2024352T3 (da) | Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling | |
| NO20055835D0 (no) | Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20042155L (no) | N-adamantylmetylderivater og mellomprodukter som farmasoytiske sammensetninger og fremgangsmater til deres fremstilling | |
| DK1523488T3 (da) | Nye thiophenglycosidderivater, fremgangsmåder til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
| DK1670458T3 (da) | 1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika | |
| DK1322158T3 (da) | Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf | |
| NO20023643D0 (no) | Forbindelser som har antitumoraktivitet, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholderdem | |
| DK1742927T3 (da) | Butanonsyrederivater, fremgangsmåder til fremstilling deraf, farmaceutiske præparater omfattende dem, og farmaceutiske applikationer deraf | |
| DK1183256T3 (da) | Puridinderivater, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem | |
| DK1707564T3 (da) | Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| NO20055167D0 (no) | Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| DK1558612T3 (da) | Imidazopyridinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK2083007T3 (da) | Tiotropiumsalte, fremgangsmåder til deres fremstilling og lægemiddelformuleringer indeholdende disse | |
| NO20052414L (no) | Nye pyrrolidin- og tiazolidinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| IS7424A (is) | Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær | |
| NO20043188L (no) | Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| DK1816121T3 (da) | 9-chlor-15-deoxyprostaglandinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som medikamenter | |
| NO20031219D0 (no) | Nye forbindelser avledet fra kinazolin, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| DK2067779T3 (da) | Tiotropiumsalte, fremgangsmåde til deres fremstilling og lægemiddelformuleringer indeholdende disse | |
| NO20054495D0 (no) | Nye anilinderivater, deres fremstilling og anvendelse som farmasoytiske forbindelser | |
| NO20031643L (no) | Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem |